【レポートの概要（一部）】
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Product Profiles
04.1.1 Iressa
04.1.2 Abraxane
04.1.3 Alimta
04.1.4 Gemzar
04.1.5 Xalkori
04.1.6 Avastin
04.1.7 Tarceva
05. Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06. Introduction
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Molecule Type
08.1 Biologics
08.2 Small Molecules
09. Market Segmentation by Route of Administration
09.1 Oral
09.2 Parenteral
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.3 AstraZeneca
18.3.1 Iressa
18.4 Celgene
18.4.1 Abraxane
18.5 Eli Lilly
18.5.1 Alimta
18.5.2 Gemzar
18.6 Pfizer
18.6.1 Xalkori
18.7 Roche
18.7.1 Avastin
18.7.2 Tarceva
18.8 Other Prominent Vendors
19. Pipeline Portfolio
20. Key Vendor Analysis
20.1 AstraZeneca plc
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Business Segmentation
20.1.4 Business Strategy
20.1.5 Revenue by Business Segmentation
20.1.6 Revenue Comparison 2011-2013
20.1.7 Sales Revenue by Geographical Segmentation
20.1.8 Key Developments
20.1.9 SWOT Analysis
20.2 Celgene
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Business Strategy
20.2.4 Business Segmentation by Revenue 2011-2013
20.2.5 Sales by Geography
20.2.6 Key Developments
20.2.7 SWOT Analysis
20.3 Eli Lilly
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation by Revenue 2013
20.3.4 Business Segmentation by Revenue 2012 and 2013
20.3.5 Sales by Geography
20.3.6 Business Strategy
20.3.7 Key Developments
20.3.8 SWOT Analysis
20.4 Pfizer
20.4.1 Key Facts
20.4.2 Business Description
20.4.3 Business Segmentation
20.4.4 Revenue by Business Segmentation
20.4.5 Revenue Comparison 2012 and 2013
20.4.6 Sales by Geography
20.4.7 Business Strategy
20.4.8 Key Developments
20.4.9 SWOT Analysis
20.5 Roche
20.5.1 Key Facts
20.5.2 Business Overview
20.5.3 Business Segmentation by Revenue 2013
20.5.4 Business Segmentation by Revenue 2012 and 2013
20.5.5 Geographical Segmentation by Revenue 2013
20.5.6 Business Strategy
20.5.7 Recent Developments
20.5.8 SWOT Analysis
21. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Non-Small-Cell Lung Cancer Market 2013-2018 (US$ billion)
Exhibit 3: Global Non-Small-Cell Lung Cancer Market Segmentation by Molecule Type
Exhibit 4: Global Non-Small-Cell Lung Cancer Market Segmentation by Molecule Type 2013
Exhibit 5: Global Non-Small-Cell Lung Cancer Market Segmentation by Route of Administration
Exhibit 6: Global Non-Small-Cell Lung Cancer Market Segmentation by Route of Administration 2013
Exhibit 7: Global Non-Small-Cell Lung Cancer Market by Geographical Segmentation 2013
Exhibit 8: Global Non-Small-Cell Lung Cancer Market Share Analysis 2013
Exhibit 9: Sales Comparison of Major Drugs 2010-2013 (US$ million)
Exhibit 10: AstraZeneca’s Iressa Sales Comparison 2006-2013 (US$ million)
Exhibit 11: Iressa Sales Comparison in Western Europe 2009-2013 (US$ million)
Exhibit 12: Iressa Sales Comparison in the Established ROW 2009-2013 (US$ million)
Exhibit 13: Iressa Sales Comparison in the Emerging Markets 2009-2013 (US$ million)
Exhibit 14: Region-wise Total Sales Comparison of Iressa 2009-2011 (US$ million)
Exhibit 15: Sales Comparison of Abraxane 2009-2013 (in US$ million)
Exhibit 16: Sales Comparison of Alimta 2003-2011 in the US (US$ million)
Exhibit 17: Sales Comparison of Alimta 2003-2011 Outside the US (US$ million)
Exhibit 18: Total Sales Comparison of Alimta 2003-2011 (US$ million)
Exhibit 19: Region-wise Total Sales Comparison of Alimta 2003-2011 (US$ million)
Exhibit 20: Sales Comparison of Gemzar in the US 2003-2011 (US$ million)
Exhibit 21: Sales Comparison of Gemzar Outside the US 2003-2011 (US$ million)
Exhibit 22: Worldwide Total Sales Comparison of Gemzar 2003-2011 (US$ million)
Exhibit 23: Region-wise Total Sales Comparison of Gemzar 2003-2011 (US$ million)
Exhibit 24: Sales Forecast of Xalkori 2013-2018 (US$ million)
Exhibit 25: Sales Comparison of Avastin and Tarceva 2005-2013 (in US$ million)
Exhibit 26: Sales Comparison of Avastin 2005-2013 (US$ million)
Exhibit 27: Sales Comparison of Tarceva 2005-2013 (US$ million)
Exhibit 28: Late Stage Pipeline Molecules for Non-Small-Cell-Lung Cancer
Exhibit 29: AstraZeneca plc: Business Segmentation
Exhibit 30: AstraZeneca plc: Revenue by Business Segmentation2013
Exhibit 31: AstraZeneca plc: Revenue by Business Segmentation 2011-2013 (US$ billion)
Exhibit 32: AstraZeneca plc: Sales Revenue by Geographical Segmentation 2013
Exhibit 33: Celgene Corp.: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 34: Celgene Corp.: Sales by Geography 2013
Exhibit 35: Eli Lilly and Co.: Business Segmentation by Revenue 2013
Exhibit 36: Eli Lilly and Co.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 37: Eli Lilly and Co.: Sales by Geography 2013
Exhibit 38: Pfizer Inc.: Business Segmentation
Exhibit 39: Pfizer Inc.: Revenue by Business Segmentation 2013
Exhibit 40: Pfizer Inc.: Revenue by Business Segmentation 2012 and 2013
Exhibit 41: Pfizer Inc.: Revenue by Geography 2013
Exhibit 42: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 43: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 44: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals Division)
Exhibit 45: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics Division)
【レポート販売概要】
■ タイトル：世界の非小細胞肺癌(NSCLC)治療市場：生物学的製剤、分子標的治療■ 英文：Global Non-small Cell Lung Cancer Market 2014-2018
■ 発行日：2014年9月10日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4123
■ 調査対象地域：グローバル
- 内視鏡クリップの世界市場2019-2023Global Endoscopic Clips Market: About this market Endoscopic clips are medical devices that are used in endoscopy and gastrointestinal surgical procedures. Technavio’s endoscopic clips market analysis considers sales from both ASCs and hospitals, clinics, and physician’s office. Our analysis also considers the sales of endoscopic clips in Asia, Europe, North America, and ROW. In 2018, the hospital …
- Aneurysm：グローバル臨床試験レビューH1, 2013Aneurysm Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Aneurysm Global Clinical Trials Review, H1, 2013" provides data on the Aneurysm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aneurysm. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
- ロシアの心臓人工弁市場見通し（～2021）Russia Prosthetic Heart Valve Procedures Outlook to 2021 Summary GlobalData’s new report, "Russia Prosthetic Heart Valve Procedures Outlook to 2021", provides key procedures data on the Russia Prosthetic Heart Valve Procedures. The report provides procedure volumes within market segments - Conventional Aortic Valve Replacement Procedures, Conventional Mitral Valve Procedures and Transcatheter Hear …
- 建材一体型太陽光発電（BIPV）の世界市場2017-2021About Building Integrated PhotovoltaicsBIPV are photovoltaic (PV) materials that are used to replace the traditional and conventional building materials such as roofs, facades, and skylights. Technavio’s analysts forecast the global building integrated photovoltaics market to grow at a CAGR of 9.78% during the period 2017-2021. [Covered in this report] The report covers the present scenario and th …
- PerkinElmer, Inc.：市場シェア分析PerkinElmer, Inc. Market Share Analysis Summary GlobalData’s new report, “PerkinElmer, Inc. Market Share Analysis” provides in-depth information on PerkinElmer, Inc.’s market position in the different medical equipment markets it operates in. The report provides PerkinElmer, Inc. market share information in two key market categories – Immuno Chemistry and Infectious Immunology. The report also pro …
- 世界におけるアレルギー血液検査デバイスの製品パイプライン動向2015Allergy Blood Tests - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Allergy Blood Tests - Pipeline Review, 2015" provides an overview of Allergy Blood Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players invol …
- United American Petroleum Corporation：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013United American Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary United American Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. T …
- ゲノム編集（ゲノム工学）の世界市場：細胞株工学、動物遺伝子工学、植物遺伝子工学In this report, the genome editing market is segmented on the basis of applications, technologies, end users, and regions. The application segments included in this report are cell line engineering, animal genetic engineering, plant genetic engineering, and other applications. The genome editing market, by technology, is categorized into CRISPR, TALEN, ZNF, antisense technology, and other technolo …
- 空港情報システム（AIS）の世界市場：AOCC、DCSAbout Airport Information Systems Airports are constantly seeking new methods to improve their operational efficiencies and enhance passenger air travel. AIS support the business goals of providing an efficient, passenger-friendly, and cost-effective airport operation. They also interface and integrate the majority of electronic information within the airport, thus ensuring the smooth flow of info …
- 中国の末梢血管処置用機器市場見通し（～2021）China Peripheral Vascular Procedures Outlook to 2021 Summary GlobalData’s new report, "China Peripheral Vascular Procedures Outlook to 2021", provides key procedures data on the China Peripheral Vascular Procedures. The report provides procedure volumes within market segments - Aortic Open Repair Procedures, Aortic Stent Graft Procedures, Carotid Artery Embolic Protection Procedures, Deep Seated A …
- ヨーロッパの子供用自転車市場About Bicycles Demand Investments in bicycle parking infrastructures are contributing to the sales of bicycles globally. With better parking facilities, more people are being encouraged to purchase and use bicycles. Folding bicycles are gaining momentum because of their portability. APAC dominated the global children's bicycle market with a share of 38.04% in 2015 followed by Europe with a share o …
- めまい(Vertigo)：世界の治験レビュー2014年下半期版Vertigo Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Vertigo Global Clinical Trials Review, H2, 2014" provides data on the Vertigo clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vertigo. It includes an overview of the trial numbers and their recruitment status as per the site of trial conductio …
- ファイバーレーザーの世界市場2020-2024Global Fiber Laser Market 2020-2024 Technavio has been monitoring the global fiber laser market and it is poised to grow by $ 8.33 bn during 2020-2024, progressing at a CAGR of 11% during the forecast period. Our reports on fiber laser market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The re …
- Colorectal Cancer：グローバル臨床試験レビューH2, 2013Colorectal Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Colorectal Cancer Global Clinical Trials Review, H2, 2013" provides data on the Colorectal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Colorectal Cancer. It includes an overview of the trial numbers and their recruitment s …
- 電圧/無効電力管理の世界市場予測（～2024年）“The volt/VAr management market is projected to grow at a CAGR of 5.9%, from 2019 to 2024.” The volt/VAr management market is projected to reach USD 568 million by 2024 from an estimated USD 427 million in 2019, at a CAGR of 5.9%. The need to reduce distribution losses & operational costs to optimize power factor, the increasing complexity of distributed energy generation, and the rising demand fo …
